In the October 11th, 2021 edition of Contemporary OB/GYN, authors (Lo, Hanna & Hedges) offer guidance to medical providers working with women who use marijuana and specific concerns for those patients that are perinatal or prenatal. The authors cite concerns over the increased levels of THC potency in recent years. Specifically, the lack of understanding […]
The Impact of Legalization of Marijuana in Illinois The Impact of Legalization of Marijuana in Illinois October 2021 – October 2021 – The Chicago High Intensity Drug Trafficking Area (HIDTA) has recognized the need to study the impact that the legalization of marijuana has had, and will continue to have, on the state of Illinois. […]
September 11, 2021 – The Rocky Mountain High Intensity Drug Trafficking Area (RMHIDTA) program has published annual reports every year since 2013 tracking the impact of legalizing recreational marijuana in Colorado. The purpose is to provide data and information so that policy makers and citizens can make informed decisions on the issue of marijuana legalization.
A study funded by the National Institute on Drug Abuse (NIDA), “The Associations between prenatal cannabis use disorder and neonatal outcomes” (Y. Shi et.al) examines potential health issues of newborns of mothers with a cannabis use disorder (CUD) at the time of delivery. Researchers reviewed over 4.8 million California birth records from 2001 – 2012. […]
The purpose of this report is to examine the effects of marijuana legalization in other states in order to provide drug policy experts and law enforcement leaders with potential impacts and consequences for Midwestern states that are contemplating the legalization of “medical” and/or “recreational” marijuana. This report will utilize data and trends from other states […]
In 1996, California became the first state to legalize marijuana for medicinal purposes with the passage of Proposition 215. Now, in 2020, recreational marijuana use is fully legal within California for individuals 21 years of age and over. This report will outline the current and potential impacts of these policies. The purpose of this report […]
The Rocky Mountain High Intensity Drug Trafficking Area (RMHIDTA) program has published annual reports every year since 2013 tracking the impact of legalizing recreational marijuana in Colorado. The purpose is to provide data and information so that policy makers and citizens can make informed decisions on the issue of marijuana legalization.
September 24, 2020 According to a recent study (Wang, Kaelber, Xu and Volkow) published in Molecular Psychiatry, nearly 11 percent of the U.S. population has a substance use disorder (SUD). Additionally, those individuals with a current SUD are at increased risks for COVID-19 as well as its adverse outcomes. This study examined over 73 million health records […]
Date: August 25, 2020 Read time: 5 Minutes Quest Diagnostics, a leader in workplace drug testing, reported that positive drug tests reached a 16-year high in 2019. Notable increases were seen in positive test results for cocaine, methamphetamine and marijuana. Marijuana continues to be the most commonly detected drug in U.S. workplace drug testing. Dr. […]
Date: 08-19-2020 A new report published in the Journal of the American Medical Association (JAMA Network) examined the changes in marijuana use rates in adults with depression from 2005 to 2016. The study, “Association of Depression With Past-Month Cannabis Use Among US Adults, Aged 20 to 59 years, 2005 to 2016” (Gorfinkel, Stohl and Hasin) […]
